TAS6417, a Novel Epidermal Growth Factor Receptor Inhibitor Targeting Exon 20 Insertion Mutations
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-1206
Full Text
Open PDFAbstract
Available in full text
Date
May 10, 2018
Authors
Publisher
American Association for Cancer Research (AACR)